1801 — Innovent Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- HK$60.61bn
- HK$52.65bn
- CNY6.21bn
Annual cashflow statement for Innovent Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -1,720 | -859 | -3,051 | -2,170 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 96.6 | 939 | 938 | -312 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -128 | -474 | -117 | 244 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,664 | -308 | -2,025 | -1,919 | — |
| Capital Expenditures | -366 | -522 | -1,848 | -1,366 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,203 | -4,663 | -851 | -69.7 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,569 | -5,185 | -2,698 | -1,435 | — |
| Financing Cash Flow Items | -89.2 | -88.6 | -132 | 73.6 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,109 | 4,912 | 5,003 | 2,892 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2,099 | -1,150 | 83.2 | -343 | — |